While antifungal prophylaxis is beneficial, it presents certain epidemiological challenges:
- Emergence of resistance: Continuous surveillance and judicious use of antifungals are necessary to mitigate this issue. - Population heterogeneity: Different populations may have varying responses to prophylaxis, necessitating tailored approaches. - Resource allocation: Ensuring that high-risk groups receive prophylaxis without overuse in low-risk populations.
